Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Ryosuke Sawaya"'
Autor:
Ryosuke Sawaya, Shigeru Yamaguchi, Yukitomo Ishi, Michinari Okamoto, Sumire Echizenya, Hiroaki Motegi, Noriyuki Fujima, Miki Fujimura
Publikováno v:
Journal of Neurosurgery; Jul2024, Vol. 141 Issue 1, p100-107, 8p
Autor:
Masaaki HOKARI, Ryosuke SAWAYA, Daisuke SHIMBO, Katsuyuki ASAOKA, Kazuki UCHIDA, Tatsuro TAKADA, Minoru AJIKI, Koji ITAMOTO
Publikováno v:
Surgery for Cerebral Stroke. 51:135-138
Autor:
Kazuki UCHIDA, Masaaki HOKARI, Daisuke SHIMBO, Ryosuke SAWAYA, Tatsuro TAKADA, Minoru AJIKI, Katsuyuki ASAOKA, Koji ITAMOTO
Publikováno v:
Surgery for Cerebral Stroke. 51:40-44
Autor:
Shigeru Yamaguchi, Michinari Okamoto, Yukitomo Ishi, Ryosuke Sawaya, Hiroaki Motegi, Minako Sugiyama, Taisuke Harada, Noriyuki Fujima, Takashi Mori, Takayuki Hashimoto, Emi Takakuwa, Atsushi Manabe, Kohsuke Kudo, Hidefumi Aoyama, Miki Fujimura
Publikováno v:
Journal of Neurosurgery: Pediatrics. 30:517-524
OBJECTIVE In patients with intracranial germ cell tumors, residual lesions are sometimes observed after completion of primary chemoradiotherapy. Although salvage resection of these end-of-treatment residual lesions is recommended for patients with no
Autor:
Michinari Okamoto, Shigeru Yamaguchi, Ryosuke Sawaya, Sumire Echizenya, Yukitomo Ishi, Sadahiro Kaneko, Hiroaki Motegi, Takuya Toyonaga, Kenji Hirata, Miki Fujimura
Background: Glioblastoma is the most offensive primary brain tumour, defined by its distinctive intratumoral hypoxia. Sequential preoperative evaluations using 18F-fluoromisonidazole (FMISO) and 18F-fluorodeoxyglucose (FDG) positron emission tomograp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73da6777395b8615f68f8feb41a40aeb
https://doi.org/10.21203/rs.3.rs-2635662/v1
https://doi.org/10.21203/rs.3.rs-2635662/v1
Autor:
Yukitomo Ishi, Takumi Era, Sayaka Yuzawa, Michinari Okamoto, Ryosuke Sawaya, Hiroaki Motegi, Shigeru Yamaguchi, Shunsuke Terasaka, Kiyohiro Houkin, Miki Fujimura
Publikováno v:
American Journal of Medical Genetics Part A. 188:1863-1867
The diagnosis of mosaicism is challenging in patients with neurofibromatosis type 2 (NF2) subset due to low variant allele frequency. In this study, we generated induced pluripotent stem cells (iPSCs) were generated from a patient clinically diagnose
Autor:
Ryosuke Sawaya, Shigeru Yamaguchi, Yukitomo Ishi, Michinari Okamoto, Sumire Echizenya, Hiroaki Motegi, Noriyuki Fujima, Miki Fujimura
Purpose: CD44 is a major cell surface receptor involved in cell adhesion and migration. The overexpression of CD44 is a poor prognostic factor in many neoplasms, including meningiomas. This study investigated the association between CD44 gene express
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6644328676cc09416bb8c43ed9cb510c
https://doi.org/10.21203/rs.3.rs-2718997/v1
https://doi.org/10.21203/rs.3.rs-2718997/v1
Autor:
Shigeru Yamaguchi, Isao Yokota, Taisuke Harada, Michinari Okamoto, Hiroyuki Kameda, Kohsuke Kudo, Yukitomo Ishi, Shunsuke Terasaka, Miki Fujimura, Ryosuke Sawaya, Hiromi Okada, Hiroaki Motegi
Publikováno v:
Neuroradiology. 64:393-396
The study aimed to investigate the clinical implications and natural history of primary intraparenchymal lesions in patients with neurofibromatosis type 2. Radiological findings of 15 neurofibromatosis type 2 cases were retrospectively collected. Twe
Autor:
Yukitomo Ishi, Shunsuke Terasaka, Michinari Okamoto, Kiyohiro Houkin, Hiroaki Motegi, Shigeru Yamaguchi, Hiroyuki Kobayashi, Ryosuke Sawaya
Publikováno v:
Neurologia medico-chirurgica
Bevacizumab (BEV) is a key anti-angiogenic agent used in the treatment for recurrent glioblastoma multiforme (GBM). The aim of this study was to investigate whether cytoreductive surgery prior to treatment with BEV contributes to prolongation of surv
Autor:
Yukitomo Ishi, Shigeru Yamaguchi, Michinari Okamoto, Ryosuke Sawaya, Shogo Endo, Hiroaki Motegi, Shunsuke Terasaka, Zen-ichi Tanei, Kanako C. Hatanaka, Shinya Tanaka, Miki Fujimura
Publikováno v:
Brain tumor pathology. 39(3)
The aim of this study was to analyze the clinical and radiological characteristics of glioblastomas (GBMs) harboring a BRAF mutation. Sequencing analysis of BRAF, IDH1/2, and TERT promoters was performed on GBM samples of patients older than 15 years